Opportunity Information: Apply for PA 17 085
The Zika Virus (ZIKV) Complications (R21) funding opportunity (NIH FOA number PA-17-085) is a discretionary grant program designed to support exploratory and developmental research focused on Zika virus and the medical and public health complications associated with infection. It uses the NIH R21 mechanism, which is commonly intended for early-stage, high-impact, or proof-of-concept studies that can generate critical preliminary data, test new ideas, or open up promising new research directions. In practical terms, this opportunity is aimed at accelerating research that can clarify how Zika causes disease, why certain complications occur, and what can be done to prevent, detect, or mitigate those outcomes.
This FOA specifically replaces an earlier announcement, PAR-16-106, which had “rolling” application due dates to enable rapid submission, review, and award for urgent or time-sensitive Zika-related projects during the height of the public health emergency. Under the older program, the final date to submit applications was January 13, 2017. PA-17-085 continues support for Zika complications research but under the newer structure and timelines described in this announcement rather than the emergency-style rolling submission approach.
The sponsoring agency is the National Institutes of Health (NIH), and the opportunity is categorized under health and social services-related research activity. Multiple CFDA program numbers are associated with the FOA (93.121, 93.173, 93.286, 93.853, 93.855, 93.856, 93.865, 93.867), which generally signals that more than one NIH institute, center, or program area may participate or that applications may align with different NIH funding streams depending on scientific scope. The posted award ceiling is $200,000, reflecting the typical scale of an R21 project budget cap, and the opportunity’s original closing date is listed as January 24, 2018. The FOA record indicates it was created on January 17, 2017.
Eligibility is broad and includes many types of domestic applicants such as state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; and Native American tribal organizations that are not federally recognized tribal governments. The opportunity is also open to nonprofit organizations both with and without 501(c)(3) status (as long as they are not institutions of higher education), for-profit organizations other than small businesses, and small businesses, as well as other applicants as allowed by NIH policy. Beyond the standard categories, the FOA explicitly highlights additional eligible applicant types, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal government agencies, U.S. territories or possessions, regional organizations, Indian/Native American Tribal Governments other than federally recognized entities, and non-domestic (non-U.S.) entities (foreign organizations). The announcement notes that applicants should consult the full FOA for complete eligibility requirements and details.
Overall, PA-17-085 is a targeted NIH research grant opportunity intended to move the science forward on Zika virus complications by funding innovative R21-style projects across a wide range of eligible organizations, including universities, governments, nonprofits, tribal entities, and domestic and foreign research organizations.Apply for PA 17 085
- The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Zika Virus (ZIKV) Complications (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.173, 93.286, 93.853, 93.855, 93.856, 93.865, 93.867.
- This funding opportunity was created on 2017-01-17.
- Applicants must submit their applications by 2018-01-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: Zika Virus (ZIKV) Complications (R21) - NIH FOA PA-17-085
1) What is the Zika Virus (ZIKV) Complications (R21) funding opportunity?
This is an NIH discretionary grant opportunity (FOA number PA-17-085) that supports exploratory and developmental research focused on Zika virus and the medical and public health complications associated with Zika infection.
2) What is the main purpose of PA-17-085?
The purpose is to accelerate research that can clarify how Zika causes disease, why certain complications occur, and what can be done to prevent, detect, or mitigate those outcomes.
3) What type of grant mechanism does this opportunity use?
This opportunity uses the NIH R21 mechanism, which is commonly intended for early-stage, high-impact, or proof-of-concept studies. These projects often generate critical preliminary data, test new ideas, or open up promising new research directions.
4) What kinds of studies does the R21 mechanism typically support under this FOA?
Based on the description provided, the FOA is oriented toward innovative, exploratory, and developmental work, including studies that generate preliminary data, test new concepts, and rapidly probe promising new research directions related to Zika complications.
5) Who is the sponsoring agency for PA-17-085?
The sponsoring agency is the National Institutes of Health (NIH).
6) What research area or category does this opportunity fall under?
The opportunity is categorized under health and social services-related research activity.
7) What is the maximum award amount (award ceiling) listed for this opportunity?
The posted award ceiling is $200,000, reflecting the typical scale of an R21 project budget cap.
8) What is the closing date for PA-17-085?
The opportunity listing shows an original closing date of January 24, 2018.
9) When was the FOA record created?
The FOA record indicates it was created on January 17, 2017.
10) Does PA-17-085 replace an earlier Zika-related funding announcement?
Yes. PA-17-085 replaces the earlier announcement PAR-16-106.
11) What was different about the earlier announcement (PAR-16-106)?
PAR-16-106 had "rolling" application due dates intended to enable rapid submission, review, and award for urgent or time-sensitive Zika-related projects during the public health emergency.
12) What was the final application submission date under PAR-16-106?
Under the older program, the final date to submit applications was January 13, 2017.
13) How is PA-17-085 structured compared with the older rolling-submission approach?
PA-17-085 continues support for Zika complications research but does so under the structure and timelines described in the newer announcement, rather than using the emergency-style rolling submission approach used previously.
14) Which CFDA program numbers are associated with PA-17-085?
Multiple CFDA program numbers are associated with the FOA: 93.121, 93.173, 93.286, 93.853, 93.855, 93.856, 93.865, and 93.867.
15) What does it mean that multiple CFDA numbers are listed?
As described, the presence of multiple CFDA program numbers generally signals that more than one NIH institute, center, or program area may participate, or that applications may align with different NIH funding streams depending on the scientific scope.
16) Who is eligible to apply for this grant opportunity?
Eligibility is broad and includes many types of domestic applicants such as state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; and Native American tribal organizations that are not federally recognized tribal governments.
17) Are nonprofit organizations eligible to apply?
Yes. Nonprofit organizations with and without 501(c)(3) status are eligible, as long as they are not institutions of higher education.
18) Are for-profit organizations eligible to apply?
Yes. For-profit organizations other than small businesses are eligible, and small businesses are also eligible.
19) Are institutions of higher education eligible to apply?
Yes. The opportunity includes eligibility for public and state-controlled institutions of higher education, as well as private institutions of higher education.
20) Are tribal entities eligible to apply?
Yes. Eligibility includes federally recognized Native American tribal governments and also Native American tribal organizations that are not federally recognized tribal governments. The FOA also highlights Indian/Native American Tribal Governments other than federally recognized entities.
21) Are U.S. territories or possessions eligible to apply?
Yes. The FOA explicitly highlights U.S. territories or possessions as eligible applicant types.
22) Are regional organizations eligible to apply?
Yes. The FOA explicitly highlights regional organizations as eligible applicant types.
23) Are faith-based or community-based organizations eligible to apply?
Yes. The FOA explicitly highlights faith-based or community-based organizations as eligible applicant types.
24) Are minority-serving institutions specifically mentioned as eligible?
Yes. The FOA explicitly highlights Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs).
25) Are eligible federal government agencies allowed to apply?
Yes. The FOA explicitly highlights eligible federal government agencies as eligible applicant types.
26) Are non-U.S. (foreign) organizations allowed to apply?
Yes. The FOA explicitly highlights non-domestic (non-U.S.) entities (foreign organizations) as eligible applicant types.
27) Does the FOA suggest checking any source for full eligibility details?
Yes. The announcement notes that applicants should consult the full FOA for complete eligibility requirements and details.
28) What is the overall goal of funding projects through PA-17-085?
Overall, the FOA aims to move the science forward on Zika virus complications by funding innovative R21-style projects across a wide range of eligible organizations, including universities, governments, nonprofits, tribal entities, and domestic and foreign research organizations.
Browse more opportunities from the same category: Health, Income Security and Social Services
Next opportunity: 1890 Facilities Grants Program
Previous opportunity: Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 17 085
Applicants also applied for:
Applicants who have applied for this opportunity (PA 17 085) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCMRR Early Career Research Award (R03) Apply for PAR 17 161 Funding Number: PAR 17 161 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $100,000 |
| Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R01) Apply for RFA HD 18 019 Funding Number: RFA HD 18 019 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R21) Apply for RFA HD 18 020 Funding Number: RFA HD 18 020 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Biomarkers: Bridging Pediatric and Adult Therapeutics (R21) Apply for PAR 17 169 Funding Number: PAR 17 169 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| NICHD Research Education Programs (R25) Apply for PAR 17 183 Funding Number: PAR 17 183 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $150,000 |
| Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21) Apply for PAR 17 187 Funding Number: PAR 17 187 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01) Apply for PAR 17 189 Funding Number: PAR 17 189 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03) Apply for PAR 17 188 Funding Number: PAR 17 188 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Human-Animal Interaction (HAI) Research (R21) Apply for PAR 17 229 Funding Number: PAR 17 229 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Resource-Related Research Projects in the Epidemiology and Prevention of Pediatric Injury (R24) Apply for PAR 17 228 Funding Number: PAR 17 228 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $375,000 |
| Human-Animal Interaction (HAI) Research (R03) Apply for PAR 17 230 Funding Number: PAR 17 230 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Human-Animal Interaction (HAI) Research (R01) Apply for PAR 17 231 Funding Number: PAR 17 231 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $499,999 |
| Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03) Apply for PAR 17 191 Funding Number: PAR 17 191 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21) Apply for PAR 17 192 Funding Number: PAR 17 192 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01) Apply for PAR 17 193 Funding Number: PAR 17 193 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43) Apply for PAR 17 199 Funding Number: PAR 17 199 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41) Apply for PAR 17 200 Funding Number: PAR 17 200 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Identification of Reproductive-Tract Specific Proteins/Transcripts for the Development of Male and Female Non-Hormonal Contraceptives (R01) Apply for RFA HD 18 002 Funding Number: RFA HD 18 002 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Point of Care Technologies for the Evaluation and Management of Obstetrics, Neonatal, and Pediatric Critical Care Patients, and for Patients with Disorders of Reproductive Tract and Infertility (R43) Apply for RFA HD 18 028 Funding Number: RFA HD 18 028 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| NICHD Exploratory-Developmental Research Grant (R21) Apply for PA 17 259 Funding Number: PA 17 259 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 17 085", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.